ArticleBMC microbiology2025
Optimization of fermentation conditions for enhanced acetylcholine and biomass production of Lactiplantibacillus plantarum AM2 using the Taguchi approach.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Optimization of hyaluronic acid production through co-culture of mutant Streptococcus zooepidemicus and Streptococcus pyogenes under controlled uv and environmental conditions.Bioprocess and biosystems engineering · 2026Article
- Comparative evaluation of glucosamine derivatives for enhanced microbial hyaluronic acid production by Streptococcus zooepidemicus and Streptococcus pyogenes.Archives of microbiology · 2026Article
- The interplay between gut microbiota and Alzheimer's disease: mechanistic insights from dysbiosis to disease modulation.Metabolic brain disease · 2026Review
- Probiotic Bacteria in Stimulating Human Physiological Responses: Metabolic Function and Overall Health.Foods (Basel, Switzerland) · 2026Review
- Improvement of the production of biomass and lipid by Papiliotrema laurentii combining flux balance analysis and central composite rotational design.Bioprocess and biosystems engineering · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to optimize the fermentation conditions and medium composition for maximum acetylcholine (ACh) and biomass production by Lactiplantibacillus plantarum AM2 using the Taguchi array design, which enables efficient identification of influential variables through minimal experimental runs. Seven key factors were evaluated: beef extract, peptone, yeast extract, glucose, pH, agitation rate, and inoculation size. The optimization process identified the most significant variables influencing ACh and biomass production, with beef extract and peptone being critical for ACh synthesis, while inoculation size was a critical determinant of biomass yield. The optimal conditions for ACh production were determined as beef extract (11 g/l), peptone (40 g/l), yeast extract (5 g/l), glucose (20 g/l), pH 5.7, no agitation, and 1% (v/v) inoculation size, resulting in a predicted ACh concentration of 490.83 pg/ml and an experimental value of 495.8 pg/ml. For biomass production, the optimal conditions were beef extract (8 g/l), peptone (10 g/l), yeast extract (20 g/l), glucose (35 g/l), pH 6.6, agitation at 150 rpm, and 4% (v/v) inoculation size, yielding a predicted biomass of 20.58 g/l and an experimental value of 21.3 g/l. The optimized conditions significantly improved ACh production (6.32-fold) and biomass production (4.56-fold) compared to basal conditions. These findings highlight the efficiency of the Taguchi approach in enhancing the production of ACh and biomass, providing insights into the functional niche of Lactiplantibacillus plantarum AM2 for potential industrial applications and its use in a symbiotic form.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.